Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001255294-14-000397
Filing Date
2014-05-12
Accepted
2014-05-12 12:54:22
Documents
18
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q 320919
2 EX31_1 ex31_1.htm EX-31.1 9198
3 EX31_2 ex31_2.htm EX-31.2 9198
4 EX32_1 ex32_1.htm EX-32.1 4073
5 GRAPHIC image_001.jpg GRAPHIC 6024
6 GRAPHIC image_002.jpg GRAPHIC 8449
7 GRAPHIC image_003.jpg GRAPHIC 3538
8 GRAPHIC image_004.jpg GRAPHIC 2698
9 GRAPHIC image_005.jpg GRAPHIC 4369
10 GRAPHIC image_006.jpg GRAPHIC 7155
11 GRAPHIC image_007.jpg GRAPHIC 4751
12 GRAPHIC image_008.jpg GRAPHIC 3351
  Complete submission text file 0001255294-14-000397.txt   2556857

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE skvi-20140331.xml EX-101.INS 254240
14 XBRL SCHEMA FILE skvi-20140331.xsd EX-101.SCH 41478
15 XBRL CALCULATION FILE skvi-20140331_cal.xml EX-101.CAL 33632
16 XBRL DEFINITION FILE skvi-20140331_def.xml EX-101.DEF 38708
17 XBRL LABEL FILE skvi-20140331_lab.xml EX-101.LAB 173226
18 XBRL PRESENTATION FILE skvi-20140331_pre.xml EX-101.PRE 138147
Mailing Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120 7024337154
SKINVISIBLE INC (Filer) CIK: 0001085277 (see all company filings)

EIN.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25911 | Film No.: 14832571
SIC: 2834 Pharmaceutical Preparations